No abstract available
MeSH terms
-
Cyclin-Dependent Kinase 5 / antagonists & inhibitors*
-
Cyclin-Dependent Kinase 5 / genetics
-
Cyclin-Dependent Kinase 5 / metabolism
-
Diabetes Mellitus, Type 2 / drug therapy
-
Diabetes Mellitus, Type 2 / prevention & control*
-
Gene Expression
-
Hypoglycemic Agents / pharmacology*
-
Hypoglycemic Agents / therapeutic use
-
Obesity / metabolism
-
PPAR gamma / metabolism*
-
Phosphorylation / drug effects
-
Rosiglitazone
-
Thiazolidinediones / pharmacology*
-
Thiazolidinediones / therapeutic use
Substances
-
Hypoglycemic Agents
-
PPAR gamma
-
Thiazolidinediones
-
Rosiglitazone
-
Cyclin-Dependent Kinase 5